The BRAIN Conference | Two-day online conference
BRAIN has published landmark papers in clinical neurology and translational neuroscience since 1878. The Guarantors of BRAIN are devoted to promoting teaching, education & research in neurology and related disciplines.
BRAIN and its Guarantors are excited to announce a new venture: The BRAIN Conference! This two-day conference will feature a selection of fantastic speakers, invited by our conference Chairs from around the globe.
They will deliver clinical teaching talks and research presentations across the range of neurology, neuropsychiatry and neuroscience.
This conference will take place on March 4-5th 2021 and be fully online.
The following areas will be covered:
Cognitive Neurology (Chair: Masud Husain)
Epilepsy (Chair: Dimitri Kullman)
Neurodegenerative (Chair: Anne Rosser),
Neurogenetics (Chair: Nicholas Wood),
Headache (Chair: Peter Goadsby),
Traumatic Brain Injury (Chair: Dave Sharp),
Nerve (Chair: Mary Reilly),
Stroke (Chair: Hugh Markus),
Neuroinflammation/MS (Chair: Olga Ciccarelli),
Movement Disorders (Chair: Anette Schrag),
Infectious Disease (Chair: Tom Solomon),
Neuropsychiatry (Chair: Paul Fletcher),
COVID Neurology (Chair: Mike Zandi) and
Muscle (Chair: Mike Hanna)
There will also have short ‘data blitz’ presentations in these sessions – BRAIN encourages all early-career researchers to submit an abstract to be considered.
Abstract submission now open!
BRAIN is keen to make this conference accessible to all – registration is only GBP 10 [free if you cannot afford this].
Register Now
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.